Lv11
38 积分 2023-10-30 加入
A New Class of Multitargeting Pt IV Anticancer Agents: Prodrugs That Release Pt II Drugs and Bioactive Moieties Tethered to Pt IV via a Tertiary Amine
31分钟前
待确认
An orally available non-nucleotide STING agonist with antitumor activity
1个月前
已完结
Phenylbutyric Acid: Simple Structure - Multiple Effects
2个月前
已完结
Triple-action Pt(IV) prodrugs of cisplatin and oxaliplatin with indole propionate and 4-phenylbutyrate ligands as potent anticancer agents
2个月前
已关闭
Probenecid, an Old Drug with Potential New Uses for Central Nervous System Disorders and Neuroinflammation
2个月前
已完结
Research Development, Optimization and Modifications of Anti-cancer Peptides
5个月前
已完结
Facile access to modified and functionalized PNAs through Ugi-based solid phase oligomerization
6个月前
已完结
Conformationally restricted and ring-fused aza-BODIPYs as promising near infrared absorbing and emitting dyes
7个月前
已完结
An ultrasound-activatable platinum prodrug for sono-sensitized chemotherapy
10个月前
已完结
Pt(IV) Prodrug Photoactivation: A Promising Strategy for Cancer Therapy
1年前
已完结
皖公网安备34019202002308
